E. H. Banitt, W. E. Coyne, J. R. Schmid, A. Mendel: Antiarrhythmics. N-(Aminoalkylene)trifluoroethoxybenzamides and N-(aminoalkylene)trifluoroethoxynaphthamide. In: J. Med. Chem., 18, 1975, S. 1130–1134, doi:10.1021/jm00245a017.
E. H. Banitt, W. R. Bronn, W. E. Coyne, J. R. Schmid: Antiarrhythmics. 2. Synthesis and antiarrhythmic activity of N-(piperidylalkyl)trifluoroethoxybenzamides. In: J. Med. Chem., 20, 1977, S. 821–826, doi:10.1021/jm00216a016.
A. M. Nia, E. Caglayan, N. Gassanov, T. Zimmermann, O. Aslan, M. Hellmich, F. Duru, E. Erdmann, S. Rosenkranz, F. Er: Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation. In: PLoS ONE. Band5, Nr.7, Juli 2010, S.e11421–e11421, doi:10.1371/journal.pone.0011421, PMID 20625396, PMC 2896398 (freier Volltext).
A. M. Nia, E. Caglayan, N. Gassanov, T. Zimmermann, O. Aslan, M. Hellmich, F. Duru, E. Erdmann, S. Rosenkranz, F. Er: Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation. In: PLoS ONE. Band5, Nr.7, Juli 2010, S.e11421–e11421, doi:10.1371/journal.pone.0011421, PMID 20625396, PMC 2896398 (freier Volltext).